{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:42:30Z","timestamp":1761093750527,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.bcmd.2011.02.004","type":"journal-article","created":{"date-parts":[[2011,3,13]],"date-time":"2011-03-13T04:36:45Z","timestamp":1299991005000},"page":"294-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Thalassemia intermedia is associated with a proatherogenic biochemical phenotype"],"prefix":"10.1016","volume":"46","author":[{"given":"Maria Eliana","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Vacquer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Paola","family":"Carta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Spiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Cocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Angius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Mandas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Dess\u00ec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2011.02.004_bb0005","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJMra050436","article-title":"Beta-thalassemia","volume":"353","author":"Rund","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2011.02.004_bb0010","first-page":"58","article-title":"Thalassemia intermedia","volume":"801","author":"Camaschella","year":"1995","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2011.02.004_bb0015","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1182\/blood.V97.11.3411","article-title":"Cardiac involvement in thalassemia intermedia: a multi-center study","volume":"97","author":"Aessopos","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2011.02.004_bb0020","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3324\/haematol.10915","article-title":"Heart disease in thalassemia intermedia: a review of the underlying pathophysiology","volume":"92","author":"Aessopos","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2011.02.004_bb0025","first-page":"1187","article-title":"Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine","volume":"89","author":"Borgna-Pignatti","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2011.02.004_bb0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bcmd.2006.04.005","article-title":"Thalassemia intermedia: revisited","volume":"37","author":"Taher","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2011.02.004_bb0035","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3324\/haematol.12484","article-title":"No evidence of cardiac iron in 20 never- or minimally-transfused patients with thalassemia intermedia","volume":"93","author":"Origa","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2011.02.004_bb0040","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3109\/03630260903351676","article-title":"Heart disease in thalassemia intermedia","volume":"33","author":"Aessopos","year":"2009","journal-title":"Hemoglobin"},{"key":"10.1016\/j.bcmd.2011.02.004_bb0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/01.CIR.0000019984.69119.4F","article-title":"Iron metabolism and development of atherosclerosis","volume":"106","author":"Auer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bcmd.2011.02.004_bb0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.beha.2004.08.020","article-title":"Hepcidin\u2014a regulator of intestinal iron absorption and iron recycling by macrophages","volume":"18","author":"Ganz","year":"2005","journal-title":"Best Prac. Res. Clin. Haematol."},{"key":"10.1016\/j.bcmd.2011.02.004_bb0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3324\/haematol.11656","article-title":"Anemia in \u03b2-thalassemia patients targets hepatic hepcidin transcript levels independently of iron metabolism genes controlling hepcidin expression","volume":"93","author":"Camberlein","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2011.02.004_bb0060","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1073\/pnas.0409808102","article-title":"Regulation of hepcidin transcription by interleukin-1 and interleukin-6","volume":"102","author":"Lee","year":"2005","journal-title":"PNAS"},{"key":"10.1016\/j.bcmd.2011.02.004_bb0065","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jacl.2008.10.008","article-title":"Plasma lipid profile and lipid peroxidation in beta-thalassemic children","volume":"6","author":"Nasr","year":"2008","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.bcmd.2011.02.004_bb0070","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1751-553X.2006.00862.x","article-title":"Lipid profile in beta-thalassemia intermedia patients: correlation with erythroid bone marrow activity","volume":"29","author":"Amendola","year":"2007","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.bcmd.2011.02.004_bb0075","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/med.20118","article-title":"Macrophages: an elusive yet emerging therapeutic target of atherosclerosis","volume":"28","author":"Tiwari","year":"2008","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bcmd.2011.02.004_bb0080","first-page":"422","article-title":"Molecular characterization of beta-thalassemia in the Sardinian population","volume":"50","author":"Rosatelli","year":"1992","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bcmd.2011.02.004_bb0085","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/01.ATV.8.6.737","article-title":"High density lipoprotein cholesterol and mortality. The Framingham Heart Study","volume":"8","author":"Wilson","year":"1988","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.bcmd.2011.02.004_bb0090","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.ATV.17.1.107","article-title":"Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men","volume":"17","author":"Goldbourt","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bcmd.2011.02.004_bb0095","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/01.CIR.97.20.2007","article-title":"C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.bcmd.2011.02.004_bb0100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM199907083410207","article-title":"The \u03b2-thalassemias","volume":"341","author":"Olivieri","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2011.02.004_bb0105","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1182\/blood.V89.3.739","article-title":"Iron-chelating therapy and the treatment of thalassemia","volume":"89","author":"Olivieri","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2011.02.004_bb0110","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0891-5849(02)01375-8","article-title":"Intracellular metal ion chelators inhibit TNF\u03b1 induced SP-1 activation and adhesion molecule expression in human aortic endothelial cells","volume":"34","author":"Zhang","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcmd.2011.02.004_bb0115","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1046\/j.1523-1747.2003.12144.x","article-title":"Iron chelators inhibit VCAM-1 expression in human dermal microvascular endothelial cells","volume":"120","author":"Koo","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bcmd.2011.02.004_bb0120","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/BF03019668","article-title":"Free hemoglobin concentrations in patients receiving massive blood transfusion during emergency surgery for trauma","volume":"47","author":"Nishiyama","year":"2000","journal-title":"Can. J. Anesth."},{"key":"10.1016\/j.bcmd.2011.02.004_bb0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1081\/HEM-120005447","article-title":"Pulmonary thromboembolism in beta-thalassemia intermedia: are we aware of this complication?","volume":"26","author":"Taher","year":"2002","journal-title":"Hemoglobin"},{"key":"10.1016\/j.bcmd.2011.02.004_bb0130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.blre.2008.04.001","article-title":"Thalassemia and hypercoagulability","volume":"22","author":"Taher","year":"2008","journal-title":"Blood Rev."},{"key":"10.1016\/j.bcmd.2011.02.004_bb0135","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood-2009-09-243154","article-title":"Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study","volume":"115","author":"Taher","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2011.02.004_bb0140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-2004-861495","article-title":"Beta-thalassemia is a modifying factor of the clinical expression of familial hypercholesterolemia","volume":"4","author":"Calandra","year":"2004","journal-title":"Semin. Vasc. Med."},{"key":"10.1016\/j.bcmd.2011.02.004_bb0145","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0306-9877(02)00264-5","article-title":"Minor thalassemia as a protective factor against cerebrovascular accidents","volume":"59","author":"Namazi","year":"2002","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bcmd.2011.02.004_bb0150","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ajh.20804","article-title":"Hypocholesterolemia in chronic anemias with increased erythropoietic activity","volume":"82","author":"Shalev","year":"2006","journal-title":"Am. J. Hematol."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979611000325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979611000325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:27:34Z","timestamp":1761049654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979611000325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1079979611000325"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2011.02.004","relation":{},"ISSN":["1079-9796"],"issn-type":[{"type":"print","value":"1079-9796"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thalassemia intermedia is associated with a proatherogenic biochemical phenotype","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2011.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}